Outlook Therapeutics resubmits ONS-5010 drug application to FDA after prior rejection
Filed June 1, 2026 · Period ending June 1, 2026 · ~1 min read
2 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade OTLK commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 1, 2026 3:18 PM